1 Min Read
LONDON, April 3 (Reuters) - Astrazeneca said on Wednesday that its MedImmune unit has bought AlphaCore Pharma, a US-based biotechnology company focused on heart treatments.
Financial details of the acquisition were not disclosed.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.